You just read:

Vigilant Biosciences Announces Poster Presentation on Measuring CD44 and Total Protein Levels to Predict Head and Neck Squamous Cell Carcinoma at 7th European Conference on Head and Neck Oncology

News provided by

Vigilant Biosciences, Inc.

06 Sep, 2016, 08:30 ET